CD8A and melanoma: Peripheral CD8+ T cells presented decreased cytotoxicity from melanoma patients, which mediated reduced target cell death compared with healthy individuals (11.88 ± 2.64% vs. 16.67 ± 4.86%; P = 0.028, Fig. 4a).